Depression and Bipolar Disorder Flashcards
Serotonin-Selective Reuptake Inhibitors (SSRI)
Fluoxetine (Prozac)
Sertraline (Zoloft)
Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)
Duloxetine (Cymbalta®)
Tricyclic antidepressants
Amitriptyline (Elavil®)
Monoamine oxidase inhibitor (MAOI)
Phenelzine (Nardil)
Selegiline (Emsam)
Atypical Antidepressants
1) Bupropion (Wellbutrin, BuSpar®) – blocks NET, DAT, may increase DA and NE release
2) Mirtazapine (Remeron) – alpha-2 adrenergic, 5HT2, 5HT3 receptor antagonist
3 Types of depression
i. Reactive Depression – short-term pharmacotherapy only if necessary
ii. Major Depression – antidepressants are most effective here. Usually requires
long term treatment of 6 months +, potentially for years.
iii. Bipolar Depression – a complex disorder that is treated with antidepressants
(controversial) , anti-manic drugs (lithium, valproate, carbamazepine,
lamotrigine) and sometimes antipsychotics.
Major Depressive Disorder
MDD is a Syndrome.
Includes Mood, but also Vegetative, Cognitive, Impulse control, Behavioral
and Somatic features.
Why is the diagnosis for MDD frequently missed?
Misinformation and stigma limit treatment; e.g., depression is due to emotional weakness, bad parenting, sinful behavior, etc.
What is the monoamine theory of depression?
Depression results from a functional deficit of monoamine transmitters at certain sites in the brain while mania results from functional excess.
Sites of antidepressant drug actions
NET- NE transporter SERT- serotonin transporter MAO- monoamine oxidase 5HTR- Serotonin receptors a1AR- alpha 1 adrenergic receptors BAR- beta adrenergic receptors
Selective Serotonin Reuptake Inhibitors (SSRI) do what?
selectively inhibit the serotonin transporter (SERT), blocking serotonin reuptake into nerve terminals.
-These drugs increase the levels of serotonin in the synaptic cleft.
Serotonin-Norepinephrine Reuptake Inhibitors (SNRI) do what?
inhibit SERT and the norepinephrine transporter (NET), blocking 5HT and NE reuptake into nerve
terminals.
-These drugs increase the levels of both serotonin and norepinephrine in
the synaptic cleft.
The Tricyclic Antidepressants (TCA) do what?
inhibit SERT and NET, blocking 5HT
and NE reuptake into nerve terminals.
-These drugs also increase the levels of both
serotonin and norepinephrine in the synaptic cleft.
Bupropion inhibits the dopamine transporter (DAT) and NET. Bupropion increases what?
the levels of both dopamine and norepinephrine in the synaptic cleft. The importance of dopamine in depression is not clear, but several drugs that are effective antidepressants act to increase synaptic dopamine levels.
Inhibition of 5HT2 receptors is most 1_________. Receptor inhibition blocks presynaptic regulation (inhibition) of neurotransmitter release, leading to
2._________ release of 5HT and so increases synaptic levels.
- Important
2. Increased
True or False? Although the monoamine hypothesis cannot completely explain the etiology of
depression, pharmacological manipulation of monoamine transmission remains the
most successful therapeutic approach.
TRUE!!!!
True or false? While pharmacological effects of antidepressants (increased NT availability are immediate, the therapeutic effects of these compounds are immediate as well.
False: the therapeutic effects of these compounds TAKE SEVERAL WEEKS to develop. The onset of therapeutic effect coincides with a compensatory down regulation in receptors.
What is the prototype SSRI?
Fluoxetine
Mechanism of action for fluoxetine?
Mechanism of action: highly selective inhibition of 5HT reuptake (serotonin transporter –SERT). >300-fold selective for SERT over NET.
Therapeutic uses for fluoxetine
Therapeutic uses.
(1) MAJOR DEPRESSIVE DISORDER
Initially produces little or no improvement.
Adaptation of the 5HT systems require time.
However, most side effects begin.
After 3-8 weeks the therapeutic effects appear.
Tolerance develops to most side effects.
Sexual dysfunction side effects may begin.
If no improvement after 6-8 weeks, try another antidepressant
Fluoxetine also approved for treatment of:
(2) Obsessive Compulsive Disorder
(3) Bulimia Nervosa
(4) Panic Disorder
(5) Premenstrual dysphoric disorder